Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 ng » 5 mg (Expand Search), 5 g (Expand Search), 5 nm (Expand Search)
Showing 81 - 100 results of 65,082 for search '(( 5 ng decrease ) OR ( 5 ((((ng decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 0.76s Refine Results
  1. 81
    Secondary efficacy endpoints for the modified intent-to-treat population.

    Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  2. 82
    Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population.

    Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  3. 83
    Source data for Fig 1.

    Source data for Fig 1. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  4. 84
    Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population.

    Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 85
    Source data for S1 and S2 Figs.

    Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  6. 86
    Source data for Fig 2.

    Source data for Fig 2. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  7. 87
    Consolidated Standards for Reporting of Trials flow diagram.

    Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  8. 88
    iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model.

    iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  9. 89
    Source data for Fig 3.

    Source data for Fig 3. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  10. 90
    Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate.

    Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 91
    Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population.

    Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  12. 92
    Diarrheal disease severity by treatment group for the modified intent-to-treat population.

    Diarrheal disease severity by treatment group for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  13. 93
    Reference mutations versus background noise across replicates.

    Reference mutations versus background noise across replicates. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 94
    Quantification and accuracy of average VAF.

    Quantification and accuracy of average VAF. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 95
    Analytical sensitivity and reproducibility.

    Analytical sensitivity and reproducibility. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 96
    Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation.

    Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 97
    Impact of mutation type on VAF quantification performance.

    Impact of mutation type on VAF quantification performance. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 98
    Schematic overview of the cross-platform study.

    Schematic overview of the cross-platform study. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 99
    Baseline clinical profile of hospitalized COVID-19 patients with low and high renalase.

    Baseline clinical profile of hospitalized COVID-19 patients with low and high renalase. by Basmah Safdar (12213257)

    Published 2022
    Save to List
    Saved in:
  20. 100
    Flow chart of study patients from all COVID-19 admissions to the institution from March to July 2020.

    Flow chart of study patients from all COVID-19 admissions to the institution from March to July 2020. by Basmah Safdar (12213257)

    Published 2022
    Save to List
    Saved in:

Search Tools: